National rectal cancer intensity-modulated radiotherapy (IMRT) guidance - coming soon
With the use of intensity-modulated radiotherapy (IMRT) for rectal cancer increasing globally, the RCR will shortly be publishing guidance for the use of IMRT/VMAT radiotherapy for rectal cancer in the UK.
The guidance will address the multiple considerations when introducing routine IMRT. These include:
- Considerations for pre-treatment investigations
- Patient preparation
- Optimal delineation of gross tumour volume (GTV)/clinical target volume (CTV)/planning target volume (PTV)
- Provision of a standard atlas for delineation of lymph nodes
- Strategies for delivery of a simultaneous integrated boost (SIB), IMRT planning and patient set-up and treatment verification.
Guidance is expected in January 2021.